FDA inspection
Amgen Inc.: FDA inspection ending Nov 30, 2023
FDA inspection 1223903 · Voluntary Action Indicated (VAI) · New Albany, OH
Key facts
| Inspection ID | 1223903 |
|---|---|
| Firm | Amgen Inc. |
| FEI number | 3020740318 |
| Address | 4150 Ganton Parkway |
| City | New Albany |
| State | OH |
| ZIP | 43054 |
| Fiscal year | 2024 |
| Inspection end date | Nov 30, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data